Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Hepatol Int. 2024 Aug;18(4):1178-1201. doi: 10.1007/s12072-024-10702-5. Epub 2024 Jun 15.
Hepatol Int. 2024.
PMID: 38878111
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review.
Miao L, Xu J, Targher G, Byrne CD, Zheng MH.
Miao L, et al.
Clin Mol Hepatol. 2022 Oct;28(4):725-738. doi: 10.3350/cmh.2022.0015. Epub 2022 Mar 14.
Clin Mol Hepatol. 2022.
PMID: 35286799
Free PMC article.
Review.
Item in Clipboard
Cite
Cite